[go: up one dir, main page]

LV10617A - 3-aizvietoti 1,2,3,4-oksatriazol-5-imina savienojumi to iegusanas metode un tos satuross farmaceitisks preparats - Google Patents

3-aizvietoti 1,2,3,4-oksatriazol-5-imina savienojumi to iegusanas metode un tos satuross farmaceitisks preparats

Info

Publication number
LV10617A
LV10617A LV940263A LV940263A LV10617A LV 10617 A LV10617 A LV 10617A LV 940263 A LV940263 A LV 940263A LV 940263 A LV940263 A LV 940263A LV 10617 A LV10617 A LV 10617A
Authority
LV
Latvia
Prior art keywords
preparation
pct
substituted
oxatriazol
pharmaceutical composition
Prior art date
Application number
LV940263A
Other languages
English (en)
Other versions
LV10617B (en
Inventor
Gunnar Keo Karup
Herbert Fritz Preikschat
Tim Niss Corell
Bodil Gyllembourg Lissau
Finn Priess Clausen
Soeren Bols Petersen
Boerge Ingvar Frisch Alhede
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of LV10617A publication Critical patent/LV10617A/lv
Publication of LV10617B publication Critical patent/LV10617B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
LVP-94-263A 1991-02-12 1994-12-23 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical praparation containing said compounds LV10617B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK023891A DK23891D0 (da) 1991-02-12 1991-02-12 3-substituerede 1,2,3,4-oxa-triazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende disse forbindelser
PCT/DK1992/000043 WO1992013847A1 (en) 1991-02-12 1992-02-11 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds
JP4071309A JPH05286950A (ja) 1991-02-12 1992-03-27 3−置換1,2,3,4−オキサトリアゾール−5−イミン化合物およびその製造方法

Publications (2)

Publication Number Publication Date
LV10617A true LV10617A (lv) 1995-04-20
LV10617B LV10617B (en) 1995-12-20

Family

ID=26063591

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-94-263A LV10617B (en) 1991-02-12 1994-12-23 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical praparation containing said compounds

Country Status (23)

Country Link
US (1) US5405857A (lv)
EP (1) EP0571485B1 (lv)
JP (1) JPH05286950A (lv)
AT (1) ATE111455T1 (lv)
BG (1) BG97988A (lv)
BR (1) BR9205624A (lv)
CA (1) CA2100160A1 (lv)
CZ (1) CZ163993A3 (lv)
DE (1) DE69200412T2 (lv)
DK (2) DK23891D0 (lv)
ES (1) ES2062891T3 (lv)
FI (1) FI933543A7 (lv)
HU (1) HUT68643A (lv)
IE (1) IE66384B1 (lv)
LT (1) LT3184B (lv)
LV (1) LV10617B (lv)
NO (1) NO932822L (lv)
PL (1) PL169685B1 (lv)
PT (1) PT100121A (lv)
RO (1) RO111190B1 (lv)
SI (1) SI9210142A (lv)
SK (1) SK78993A3 (lv)
WO (1) WO1992013847A1 (lv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4321109C2 (de) * 1993-06-25 1998-01-29 Sanol Arznei Schwarz Gmbh Pharmakologisch aktive Verbindungen mit Nitrosohydrazinpartialstruktur
AU8057194A (en) * 1994-10-07 1996-05-02 A/S Gea Farmaceutisk Fabrik Substituted 3-phenyl-1,2,3,4-oxatriazole-5-imines useful for the treatment of asthma and thrombosis
US8741402B2 (en) * 2004-04-02 2014-06-03 Curwood, Inc. Webs with synergists that promote or preserve the desirable color of meat
US8470417B2 (en) 2004-04-02 2013-06-25 Curwood, Inc. Packaging inserts with myoglobin blooming agents, packages and methods for packaging
US8110259B2 (en) 2004-04-02 2012-02-07 Curwood, Inc. Packaging articles, films and methods that promote or preserve the desirable color of meat
US7867531B2 (en) 2005-04-04 2011-01-11 Curwood, Inc. Myoglobin blooming agent containing shrink films, packages and methods for packaging
US8053047B2 (en) 2004-04-02 2011-11-08 Curwood, Inc. Packaging method that causes and maintains the preferred red color of fresh meat
US8029893B2 (en) 2004-04-02 2011-10-04 Curwood, Inc. Myoglobin blooming agent, films, packages and methods for packaging
US8545950B2 (en) * 2004-04-02 2013-10-01 Curwood, Inc. Method for distributing a myoglobin-containing food product
AU2010204723A1 (en) * 2009-01-14 2011-08-18 The Salk Institute For Biological Studies Methods for screening and compounds that protect against amyloid diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2015878B (en) * 1978-03-10 1982-05-26 Shell Int Research Biocidal compositions
US4239355A (en) 1979-02-05 1980-12-16 Vought Corporation Visual simulator projection system
US4329355A (en) * 1979-03-01 1982-05-11 Henry David W Mesoionic antitumor compositions and methods for using the same in the treatment of cancer
JP2708500B2 (ja) 1988-09-27 1998-02-04 三菱電機株式会社 積層形燃料電池
JP2905041B2 (ja) * 1993-07-02 1999-06-14 三菱電機株式会社 メッセージ送受信装置
JPH0720904A (ja) * 1993-07-05 1995-01-24 Toshiba Corp プロセス制御装置のリミッタ設定装置
JP2009102700A (ja) 2007-10-24 2009-05-14 Sumitomo Kinzoku Kozan Siporex Kk 軽量気泡コンクリート補強鉄筋用防錆剤

Also Published As

Publication number Publication date
EP0571485B1 (en) 1994-09-14
WO1992013847A1 (en) 1992-08-20
DE69200412T2 (de) 1995-02-16
SK78993A3 (en) 1994-03-09
NO932822D0 (no) 1993-08-09
FI933543A0 (fi) 1993-08-11
BG97988A (bg) 1994-06-30
PL169685B1 (pl) 1996-08-30
FI933543L (fi) 1993-08-11
DK0571485T3 (da) 1994-10-17
HUT68643A (en) 1995-07-28
LV10617B (en) 1995-12-20
CZ163993A3 (en) 1994-01-19
DK23891D0 (da) 1991-02-12
SI9210142A (en) 1995-08-31
EP0571485A1 (en) 1993-12-01
US5405857A (en) 1995-04-11
IE66384B1 (en) 1995-12-27
ES2062891T3 (es) 1994-12-16
ATE111455T1 (de) 1994-09-15
CA2100160A1 (en) 1992-08-13
LT3184B (en) 1995-03-27
BR9205624A (pt) 1994-11-08
IE920436A1 (en) 1992-08-12
DE69200412D1 (de) 1994-10-20
LTIP298A (en) 1994-08-25
PT100121A (pt) 1993-05-31
RO111190B1 (ro) 1996-07-30
NO932822L (no) 1993-08-09
JPH05286950A (ja) 1993-11-02
FI933543A7 (fi) 1993-08-11
HU9302323D0 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
DE59407237D1 (de) Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
NO20002788D0 (no) Nye forbindelser
SE9701398D0 (sv) Novel compounds
NL970045I1 (nl) Desulfatohirudinen, werkwijze voor hun bereiding en farmaceutische middelen.
EE9800080A (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
UA49796C2 (uk) Ангідрат пароксетин гідрохлориду, спосіб його одержання, сольвати пароксетин гідрохлориду, спосіб їх одержання, спосіб лікування та/або профілактики та фармацевтична композиція
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
LV10617A (lv) 3-aizvietoti 1,2,3,4-oksatriazol-5-imina savienojumi to iegusanas metode un tos satuross farmaceitisks preparats
UA45942A (uk) 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція
DE60233433D1 (de) PHARMAZEUTISCHE ZUBEREITUNG enthaltend ein Catechin, Ascorbinsäure, Prolin und Lysin ZUR BEHANDLUNG VON NEOPLASTISCHEN KRANKHEITEN
ATE303362T1 (de) Chalcon-derivate mit antiproliferativer aktivität
ATE368110T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
PT77374B (fr) Procede de preparation de nouveaux derives de la sulfonyluree
ATE266027T1 (de) Optisch aktives pyridyl-4h-1,2,4-oxadiazinderivat und seine verwendung zur behandlung von gefässkrankheiten
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
ATE27157T1 (de) Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
IL88726A0 (en) Dihydrothienobenzodiazepinone derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
DE69814204D1 (de) Verfahren zur Herstellung von 2,2'-bis(Hydroxymethyl)alkanal und 2,2'-bis(Hydroxymethyl)alkansäure
FR2580648B1 (fr) Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
DE3874606D1 (de) Behandlung von viraler infektion.
DK0808306T3 (da) Hidtil ukendte pyridin- eller pyridazinderivater, fremgangsmåder til fremstilling deraf og lægemidler indeholdende disse fo
FR2585020B1 (fr) Nouvelle substance biologiquement active, appelee girolline, extraite de l'eponge pseudaxinyssa cantharella, son procede de preparation et les compositions pharmaceutiques qui la contiennent